• American Biotech Labs (ABL; Salt Lake City) said that the company received FDA approval to market its ASAP Wound Dressing Gel "for the topical management of minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin irritations." The product uses ABL's innovative SilverSol Technology, which has garnered multiple patents in the U.S. and several countries throughout the world, including a broad-use patent that provides the company with exclusive rights to use its silver-based products to combat many of the world's most destructive pathogens, including malaria, tuberculosis, MRSA and HIV. ABL has performed extensive anti-microbial studies against bacteria, yeast, fungus and other pathogens.

• CombiMatrix (Mukilteo, Washington) said that Karine Hovanes, PhD, has joined its wholly owned subsidiary, Combimatrix Molecular Diagnostics (CMDX), as its Laboratory Director. Dr. Hovanes is a Diplomat of the American Board of Medical Genetics in Clinical Molecular Genetics and Clinical Cytogenetics and is also licensed in New York and California in both cytogenetics and molecular genetics. Dr. Hovanes joins CMDX from Laboratory Corporation of America. CombiMatrix specializes in drug development, genetic analysis, molecular diagnostics, nanotechnology and defense products.

• Covidien (Boulder, Colorado) reported the global launch of its Alarm Management System for the Nellcor OxiMax N-600x pulse oximeter. The company says the OxiMax N-600x pulse oximeter is an oximeter that delivers accurate, reliable readings even during low perfusion and signal interference. The Alarm Management System software upgrade for the OxiMax N-600-x pulse oximeter brings together the technologies in the OxiMax SPD alert and SatSeconds alarm management with two new views that compile and display the information without adding to the current set of monitors and sensors. The OxiMax SPD alert uses an algorithm incorporating a patient's rate, severity, frequency and duration of desaturation to detect patterns indicative of repetitive reductions in airflow in adults. SatSeconds alarm management is a clinician controlled feature that reduces alarm fatigue without sacrificing patient safety by differentiating between serious hypoxemia and minor transient events.

• ExpressMD Solutions (Berkeley Heights, New Jersey) said that its remote patient health monitoring system has received 510(k) market clearance from the FDA. ExpressMD plans to initiate manufacturing and sales of its Electronic House Call monitoring devices and services immediately. The Electronic House Call System will be used by healthcare professionals who manage patients with chronic conditions, such as heart disease, COPD (Chronic Obstructive Pulmonary Disease) and diabetes. Patients are able to use the monitoring devices located in their home to measure their vital signs and to motivate them through education and reminders. The Electronic House Call monitor securely transmits this information to its data center making it conveniently available to each licensed care provider via a secure website. By remotely receiving patient data daily, licensed care providers can adjust treatment accordingly and provide an enhanced level of care.

• iCAD (Nashua, New Hampshire) said it received FDA clearance for PrecisionPoint, the company's interventional planning solution for breast MRI that can make biopsies easier and faster. PrecisionPoint will be offered as an integrated module within the company's CADvue breast MRI image review software. "We continue to improve upon our software offerings to provide clinicians increasingly accurate tools to aid in the detection of breast cancer. Our new PrecisionPoint software enables the user to pinpoint exactly where the biopsy is needed without the need to manually calculate the location and depth of the lesion," said Rick Ortega, director of MRI programs at iCAD. "Faster and more reliable biopsies could help reduce the need for repeat exams and aid in quicker clinical decision making and treatment for patients."

No Comments